A cheap blood marker might flag delirium risk in elderly surgery patients

NCT ID NCT07741175

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study asks whether a routine blood test measure called the neutrophil-lymphocyte ratio (NLR) can help predict delirium—a state of sudden confusion—in older adults after hip fracture surgery. Delirium is a common and serious complication in elderly patients, and inflammation may play a role. Researchers will track 100 patients aged 65 and older, measuring NLR from standard blood counts and checking for delirium using a validated assessment tool. If NLR proves useful, it could offer a simple, inexpensive way to identify high-risk patients earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
neutrophil-lymphocyte ratio (NLR) blood test
What this could lead to
If NLR proves reliable, it could become a simple, low-cost tool to identify older patients at higher risk of delirium after hip surgery, enabling earlier monitoring and preventive care.
What could go wrong
This is a single-center study with 100 participants, and NLR is a general inflammation marker that may not be specific enough to predict delirium reliably in all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELIRIUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ali Emre Karakis

    Ankara, 06200, Turkey (Türkiye)

  • Dr. Abdurrahman Yurtaslan OTRH

    Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.